BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 6, 2020
View Archived Issues
Where exercise-induced IL-6 comes and goes
Read More
How does innate immunity remember? Not via polycomb
Read More
Vir and Alnylam identify development candidate targeting the SARS-CoV-2 genome
Read More
Model created for multiple system atrophy-C and primary progressive multiple sclerosis
Read More
Positive topline results from global phase III INNO2VATE program of vadadustat
Read More
First patients enrolled in pivotal MACOVIA study of MultiStem in COVID-19-induced ARDS
Read More
Innovation announces new agreement to study inhibitory effects of brilacidin on SARS-CoV-2
Read More
Phase I results of bivalent CD19/CD22 CAR T cells in patients with ALL
Read More
Rafael Pharmaceuticals and Roswell Park Comprehensive Cancer Center to evaluate CPI-613
Read More
Unigen divulges tyrosinase and melanin inhibitors
Read More
Nanjing Sanhome Pharmaceutical synthesizes TGFBR1 inhibitors
Read More
Low-dose sorafenib shown to ameliorate NASH
Read More
Servier and Vernalis describe USP7 inhibitors
Read More
Medshine Discovery identifies TLR8 agonists for HBV infection
Read More
Heptares Therapeutics presents new histamine H4 receptor antagonists
Read More
Positive topline data from the UNITY-CLL phase III study
Read More
ORIC Pharmaceuticals' OP-5244 reverses immunosuppression in vivo
Read More
Veru reports positive phase Ib data for VERU-111
Read More
Novel animal model of cardiac reperfusion injury
Read More
FDA clears Kiadis to begin phase II study of K-NK-002 produced with PM21
Read More
Enrollment on track in phase IIb GALACTIC-1 study of GB-0139 in IPF
Read More
Genzyme initiates phase III study of venglustat in late-onset GM2 gangliosidosis
Read More
ProMIS identifies novel antagonists against RACK1 for neurodegenerative diseases
Read More
Health Canada clears initiation of phase II study of LAU-7b for COVID-19
Read More
FDA approves Farxiga for HFrEF
Read More